Calvisi DF - Search Results

1

Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways.

Wang C, Delogu S, Ho C, Lee SA, Gui B, Jiang L, Ladu S, Cigliano A, Dombrowski F, Evert M, Calvisi DF, Chen X. Wang C, et al. Among authors: calvisi df. J Hepatol. 2012 Sep;57(3):577-83. doi: 10.1016/j.jhep.2012.04.026. Epub 2012 May 19. J Hepatol. 2012. PMID: 22617155 Free PMC article.

2

Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis.

Pascale RM, Simile MM, De Miglio MR, Muroni MR, Calvisi DF, Asara G, Casabona D, Frau M, Seddaiu MA, Feo F. Pascale RM, et al. Among authors: calvisi df. Hepatology. 2002 Jun;35(6):1341-50. doi: 10.1053/jhep.2002.33682. Hepatology. 2002. PMID: 12029619

3

Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis.

De Miglio MR, Pascale RM, Simile MM, Muroni MR, Calvisi DF, Virdis P, Bosinco GM, Frau M, Seddaiu MA, Ladu S, Feo F. De Miglio MR, et al. Among authors: calvisi df. Cancer Res. 2002 Aug 1;62(15):4459-63. Cancer Res. 2002. PMID: 12154055

4

Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital.

Calvisi DF, Ladu S, Factor VM, Thorgeirsson SS. Calvisi DF, et al. Carcinogenesis. 2004 Jun;25(6):901-8. doi: 10.1093/carcin/bgh083. Epub 2004 Jan 23. Carcinogenesis. 2004. PMID: 14742323

5

Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice.

Calvisi DF, Factor VM, Ladu S, Conner EA, Thorgeirsson SS. Calvisi DF, et al. Gastroenterology. 2004 May;126(5):1374-86. doi: 10.1053/j.gastro.2004.02.014. Gastroenterology. 2004. PMID: 15131798

6

Disregulation of E-cadherin in transgenic mouse models of liver cancer.

Calvisi DF, Ladu S, Conner EA, Factor VM, Thorgeirsson SS. Calvisi DF, et al. Lab Invest. 2004 Sep;84(9):1137-47. doi: 10.1038/labinvest.3700147. Lab Invest. 2004. PMID: 15220935 Free article.

7

Vitamin E down-modulates iNOS and NADPH oxidase in c-Myc/TGF-alpha transgenic mouse model of liver cancer.

Calvisi DF, Ladu S, Hironaka K, Factor VM, Thorgeirsson SS. Calvisi DF, et al. J Hepatol. 2004 Nov;41(5):815-22. doi: 10.1016/j.jhep.2004.07.030. J Hepatol. 2004. PMID: 15519655

8

Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer.

Calvisi DF, Conner EA, Ladu S, Lemmer ER, Factor VM, Thorgeirsson SS. Calvisi DF, et al. J Hepatol. 2005 Jun;42(6):842-9. doi: 10.1016/j.jhep.2005.01.029. Epub 2005 Apr 8. J Hepatol. 2005. PMID: 15885355

9

Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.

Calvisi DF, Ladu S, Gorden A, Farina M, Conner EA, Lee JS, Factor VM, Thorgeirsson SS. Calvisi DF, et al. Gastroenterology. 2006 Apr;130(4):1117-28. doi: 10.1053/j.gastro.2006.01.006. Gastroenterology. 2006. PMID: 16618406

10

Altered methionine metabolism and global DNA methylation in liver cancer: relationship with genomic instability and prognosis.

Calvisi DF, Simile MM, Ladu S, Pellegrino R, De Murtas V, Pinna F, Tomasi ML, Frau M, Virdis P, De Miglio MR, Muroni MR, Pascale RM, Feo F. Calvisi DF, et al. Int J Cancer. 2007 Dec 1;121(11):2410-20. doi: 10.1002/ijc.22940. Int J Cancer. 2007. PMID: 17680562

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters